Brief: Cns Pharmaceuticals says Cash On Hand And Cash Raised In Oct Sufficient To Fund Operations
Nov 15 (Reuters) - CNS Pharmaceuticals Inc CNSP.O :
* CNS PHARMACEUTICALS INC- CURRENT EXPECTATION IS CASH ON
HAND
AND CASH RAISED IN OCT SUFFICIENT TO FUND OPERATIONS THROUGH THE
END Q4 2023
Further company coverage: CNSP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CNS Pharmaceuticals
See all newsCNS Pharmaceuticals Q2 net loss widens, cash rises after financing
CNS Pharmaceuticals Inc expected to post a loss of 24 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:44 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM
Brief: Cns Pharmaceuticals Appoints Rami Levin As CEO Effective Jan 1, 2026